This topic contains a solution. Click here to go to the answer

Author Question: A uniform 120-lb beam is supported in a horizontal position by a pin and cable as shown in the ... (Read 716 times)

savannahhooper

  • Hero Member
  • *****
  • Posts: 576

A uniform 120-lb beam is supported in a horizontal position by a pin and cable as shown in the figure. What is the magnitude of the force by the pin on the beam?
 
   


   
  a.
  94 lb
   
  b.
  88 lb
   
  c.
  63 lb
   
  d.
  75 lb
   
  e.
  150 lb

Question 2

A uniform beam having a mass of 60 kg and a length of 2.8 m is held in place at its lower end by a pin. Its upper end leans against a vertical frictionless wall as shown in the figure. What is the magnitude of the force the pin exerts on the beam?
 
   


   
  a.
  0.68 kN
   
  b.
  0.57 kN
   
  c.
  0.74 kN
   
  d.
  0.63 kN
   
  e.
  0.35 kN



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bimper21

  • Sr. Member
  • ****
  • Posts: 309
Answer to Question 1

d

Answer to Question 2

a




savannahhooper

  • Member
  • Posts: 576
Reply 2 on: Jul 28, 2018
Great answer, keep it coming :)


meganmoser117

  • Member
  • Posts: 303
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

More than one-third of adult Americans are obese. Diseases that kill the largest number of people annually, such as heart disease, cancer, diabetes, stroke, and hypertension, can be attributed to diet.

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

ACTH levels are normally highest in the early morning (between 6 and 8 A.M.) and lowest in the evening (between 6 and 11 P.M.). Therefore, a doctor who suspects abnormal levels looks for low ACTH in the morning and high ACTH in the evening.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library